BPC-157 Peptide
£55.00
Out of stock
The Healing Multitasker: BPC-157's Regenerative Power in Animal Studies
Body Protection Compound-157 (BPC-157), a stable peptide derived from human gastric juice, has shown remarkable and pleiotropic effects in numerous preclinical animal studies, highlighting its potential as a regenerative and cytoprotective agent. These findings, primarily in rodent models, demonstrate a consistent and powerful ability to accelerate healing across various tissues, an effect attributed to its influence on key healing pathways.
A primary mechanism observed is its potent pro-angiogenic effect—the promotion of new blood vessel formation. BPC-157 appears to stabilize the endothelium and enhance the activity of pathways like the VEGFR2-NO system and ERK1/2 signaling, rapidly improving blood flow to injured sites. This mechanism underpins its successful role in treating damage to tendons, ligaments, muscles, and bones, where it has been shown to accelerate the healing of transected tissues and improve functional, structural, and biomechanical outcomes, even in compromised conditions like corticosteroid impairment or poor blood supply.
Beyond musculoskeletal repair, BPC-157 exhibits significant cytoprotective and anti-inflammatory properties, particularly in the gastrointestinal tract. In animal models, it consistently reduces lesions induced by Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) throughout the stomach and small intestine, demonstrating a strong role in maintaining mucosal integrity. Its therapeutic influence extends to the central nervous system as well, where studies suggest it can improve recovery and functional outcomes after spinal cord and brain injuries in rats by counteracting edema, neuronal loss, and demyelination. In summary, animal research positions BPC-157 as a broad-spectrum healing compound that actively promotes tissue repair, reduces inflammation, and offers systemic protective effects.
Ingredients Per Capsule
BPC-157 500mcg